1. Testing of tissue specimens obtained from SARS-CoV-2 nasopharyngeal swab-positive donors.
- Author
-
Greenwald, Melissa, Namin, Shabnam, Zajdowicz, Jan, Jones, Alyce, Fritts, Linda, Kuehnert, Matthew, Ray, Gregory, and Miller, Chris
- Subjects
Bone ,Dermis ,Fascia lata ,Heart valves ,Infection ,Musculoskeletal tissue ,RNA ,SARS-CoV-2 ,Tendons ,Tissue donor ,Tissues ,Transplantation ,Vascular tissue ,Viral ,Humans ,SARS-CoV-2 ,COVID-19 ,RNA ,Viral ,Nasopharynx ,Tissue Donors ,Female ,Male ,Middle Aged ,Adult ,Aged ,COVID-19 Nucleic Acid Testing ,Specimen Handling - Abstract
Risk for transmission of SARS-CoV-2 through allogeneic human tissue transplantation is unknown. To further evaluate the risk of virus transmission, tissues were obtained from deceased donors who had tested positive for SARS-CoV-2 RNA via nasopharyngeal swab. This study evaluated an array of human tissues recovered for transplantation, including bone, tendon, skin, fascia lata, vascular tissues, and heart valves. Tissue samples and plasma or serum samples, if available, were tested for viral RNA (vRNA) using a real time PCR system for the presence of virus RNA. All samples were tested in quadruplicate for both subgenomic (sgRNA) and genomic (gRNA) RNA encoding the SARS-CoV-2 nucleocapsid gene. Amplification of a cellular housekeeping gene served as the positive control for every sample. A total of 47 tissue samples from 17 donors were tested for SARS-CoV-2 RNA. Four donors had plasma or serum available for paired testing. SARS-CoV-2 RNA was not detected from any tissue or plasma/serum sample tested. Based on these findings, risk of transmission through the transplantation of tissue types studied from SARS-CoV-2 infected donors is likely to be low.
- Published
- 2024